Michael Barbella, Managing Editor03.03.21
The COVID-19 pandemic continued to wreak havoc on the medtech industry late last year.
Total M&A deal value in the final three months of 2020 was $11.67 billion, a 75.2 percent decrease compared with the third quarter (ended Sept. 30, 2020) and an 11.4 percent decrease compared with the final quarter of 2019, according to GlobalData’s deals database.
The United States held an 89.1 percent share of the global medical devices industry M&A deal value that totalled $13.1 billion in Q4 2020.
In terms of deal activity, the United States recorded 65 deals during Q4 2020, marking a rise of 6.6 percent over the previous quarter and a rise of 18.2 percent over the last four-quarter average.
The top five medical devices industry M&A deals accounted for 79.7 percent of the overall value during Q4 2020.
The combined value of the top five medical devices M&A deals stood at $9.3 billion, against the overall value of $11.67 billion recorded for the quarter.
The top five medical devices industry deals of Q4 2020 tracked by GlobalData were:
Total M&A deal value in the final three months of 2020 was $11.67 billion, a 75.2 percent decrease compared with the third quarter (ended Sept. 30, 2020) and an 11.4 percent decrease compared with the final quarter of 2019, according to GlobalData’s deals database.
The United States held an 89.1 percent share of the global medical devices industry M&A deal value that totalled $13.1 billion in Q4 2020.
In terms of deal activity, the United States recorded 65 deals during Q4 2020, marking a rise of 6.6 percent over the previous quarter and a rise of 18.2 percent over the last four-quarter average.
The top five medical devices industry M&A deals accounted for 79.7 percent of the overall value during Q4 2020.
The combined value of the top five medical devices M&A deals stood at $9.3 billion, against the overall value of $11.67 billion recorded for the quarter.
The top five medical devices industry deals of Q4 2020 tracked by GlobalData were:
- Koninklijke Philips’ $2.8 billion acquisition of BioTelemetry
- The $2.15 billion acquisition of Thrive Earlier Detection by Exact Sciences
- AdaptHealth’s $2 billion acquisition of AeroCare
- The $1.5 billion acquisition of Butterfly Network by Longview Acquisition
- Steris’ acquisition of Key Surgical for $850 million.